Bringing healthcare providers across the District of Columbia the latest news, events, and resources to improve care for patients with substance use disorders and chronic pain management.
Illicitly Manufactured Fentanyl–Involved Overdose Deaths with Detected Xylazine — United States, January 2019–June 2022
The CDC published a report which revealed a rise of 276% in the monthly percentage of deaths involving illicitly manufactured fentanyl with detected xylazine, from 2.9% to 10.9%, across 20 states and DC
Framing harm reduction as part of an integrated approach to reduce drug overdose: A randomized message testing experiment in a nationally representative sample of U.S. adults, 2022
Opioid and stimulant attributed treatment admissions and fatal overdoses: Using national surveillance data to examine the intersection of race, sex, and polysubstance use, 1992–2020
